ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 75 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,261,000 | -31.5% | 2,740,000 | 0.0% | 0.01% | -38.5% |
| Q2 2020 | $16,440,000 | -20.3% | 2,740,000 | 0.0% | 0.01% | -40.9% |
| Q1 2020 | $20,632,000 | -45.2% | 2,740,000 | 0.0% | 0.02% | -38.9% |
| Q4 2019 | $37,675,000 | +242.8% | 2,740,000 | +196.2% | 0.04% | +200.0% |
| Q3 2019 | $10,989,000 | -15.1% | 925,000 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $12,941,000 | -21.8% | 925,000 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $16,539,000 | +13.7% | 925,000 | 0.0% | 0.02% | -5.3% |
| Q4 2018 | $14,550,000 | – | 925,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
| RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
| Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
| Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
| Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
| Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
| Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |